Application of nisin as a potential drug candidate for electrochemotherapy
Frontiers in Oncology · 28.11.2025 · 15
DOI: 10.3389/fonc.2025.1689261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 28.11.2025. Verfasst von Olga Michel und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Wrocław, Poland. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lietuvos Mokslo Taryba.
Abstract (Originalsprache)
Introduction
Electroporation (EP) is a technique that transiently increases the permeability of the cell membrane through the application of high-voltage electric pulses, facilitating the intracellular delivery of therapeutic agents or the selective ablation of cells. Combination of EP with cytotoxic drugs—most commonly bleomycin or cisplatin—is termed electrochemotherapy (ECT), which markedly enhances drug efficacy and permits targeted, locally controlled treatment with reduced systemic exposure. Currently, in addition to microsecond (µs) pulses, nanosecond (ns) pulses are being proposed for clinical use to mitigate certain ECT-associated side effects. However, achieving robust permeabilization with nsPEF typically requires higher electric fields. Nisin is a polycyclic antibacterial peptide with anticancer potential that can be leveraged in this context.
Methods
To date, the permeabilizing properties of nisin have been employed alongside an external electric field exclusively in bacterial systems and artificial membranes. In this study, we investigated the impact of nisin on membrane permeabilization, resealing, and viability of 4T1 breast cancer cells exposed to microsecond and nanosecond electric pulses of varying field strengths and pulse frequencies.
Results
Across all experimental conditions, nisin reduced the threshold voltage necessary for effective permeabilization and increased treatment-induced cell mortality.
Discussion
Since nisin is non-toxic by itself, it represents a promising candidate for electrochemotherapy, potentially supporting its wider clinical application in the future.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Wrocław, Poland.
- Department of Immunology and Bioelectrochemistry, State Research Institute Centre of Innovative Medicine, Vilnius, Lithuania.
- Faculty of Electronics, Vilnius Gediminas Technical University, Vilnius, Lithuania.
- Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Förderung
- Lietuvos Mokslo Taryba
Zitieren
APA
Michel, O., Lekešytė, B., Malyško-Ptašinskė, V., Morozas, A., Malakauskaitė, P., Mickevičiūtė-Zinkuvienė, E., Želvys, A., Ivaška, J., Kulbacka, J., & Novickij, V. (2025). Application of nisin as a potential drug candidate for electrochemotherapy. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1689261
Vancouver
Michel O, Lekešytė B, Malyško-Ptašinskė V, Morozas A, Malakauskaitė P, Mickevičiūtė-Zinkuvienė E, et al. Application of nisin as a potential drug candidate for electrochemotherapy. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1689261
BibTeX
@article{Michel2025,
author = {Michel, Olga and Lekešytė, Barbora and Malyško-Ptašinskė, Veronika and Morozas, Arnoldas and Malakauskaitė, Paulina and Mickevičiūtė-Zinkuvienė, Eglė and Želvys, Augustinas and Ivaška, Justinas and Kulbacka, Julita and Novickij, Vitalij},
title = {Application of nisin as a potential drug candidate for electrochemotherapy},
journal = {Frontiers in Oncology},
year = {2025},
volume = {15},
doi = {10.3389/fonc.2025.1689261}
}
EUVIMED